From Hit to Clinic: Isogenica and Charles River Collaborate to Accelerate Next-Generation Peptide and VHH Discovery
Every breakthrough begins with discovery. Isogenica, a leader in synthetic VHH antibody and peptide discovery, has announced a collaboration with Charles River, a leading, global provider of drug discovery, development, and manufacturing solutions, to help biotech companies streamline discovery and accelerate progress toward clinic-ready therapeutics. This collaboration unites Isogenica’s…
Blue Smile celebrates 15 years of supporting children's mental health
Local charity Blue Smile celebrated its 15th anniversary on 28th May with a reception hosted by Downing College, Cambridge.
STEMCELL Technologies announces acquisition of Cellular Highways
Vancouver, British Columbia and Cambridge, United Kingdom, June 02, 2025 – STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell sorting technologies with applications in cell and gene…
Overcoming challenges in Pulmonary Hypertension
Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery pressure [1].
How to build a content strategy that works: A guide for science and tech marketers
It’s not enough to have great content for science and tech marketers - you need a strategy that aligns with your commercial goals and drives real ROI. So how do you build one?
AI-driven multiomics in health: our 2025 roundtable insights
We recently convened a multidisciplinary group of health clinicians, researchers, academics, policy makers and industry professionals to find out where they are using - or expect to use -AI-driven multiomics, and where barriers to uptake lie.
The EpiCentre Haverhill to host Cambridge wide open day on 11th June
New venue announcement for Cambridge Wide Open Day! The EpiCentre is proud to open its doors for a morning of networking, innovation, and discovery. As part of this exciting day, we’re featuring a special showcase from one of our pioneering companies – KluraLabs.
Fujifilm rebrands life sciences companies to strengthen position as strategic Partners for Life, offering end-to-end solutions
FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a cell culture pioneer FUJIFILM Diosynth Biotechnologies will be known as FUJIFILM Biotechnologies, serving global partners seek
Ireland adopts Cambridge-developed method to monitor early prostate cancer
Development of the first evidence-based tool that helps clinicians actively monitor early prostate cancer in newly diagnosed patients has won important recognition in Ireland following research in Cambridge.
The strategic importance of private 5G networks
In the rapidly evolving landscape of emergency response, connectivity, reliability, and security are paramount. Private 5G networks are emerging as a transformative force, providing first responders across the United States with unprecedented communication capabilities.
Childhood kidney cancer has millions of genetic changes, opening door to possible treatments
Researchers have uncovered that some childhood cancers have a substantially higher number of DNA changes than previously thought, changing the way we view children’s tumours and possibly opening up new or repurposed treatment options.
Dinosaurs could hold key to cancer discoveries
New study highlights the importance of preserving fossilised soft tissues.
Want to know the secret to better business and a more fulfilled team?
In a world obsessed with strategy and tech, the real competitive edge lies in understanding people. Human behaviour training isn’t just “soft skills”—it’s the hard truth behind better leadership, faster conflict resolution, stronger communication, and thriving teams. By recognising your own behavioural patterns and learning to adapt to others’, you unlock a powerful shift: fewer…
Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development
Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular interactionsCollaboration allows researchers to progress rapidly from DN
Cambridge’s success in fund-raising for start-ups and scale-ups benefits the whole region
A new analysis by Dealroom for Founders at the University of Cambridge showed that Cambridge startups and scaleups raised an impressive $2.3 billion in 2024, the second-best year on record and almost double 2023’s $1.2 billion that is great news for the Cambridge region as a whole.
Sapio Sciences appoints Gordon McCall as Chief Operating Officer to drive global operational excellence
New role underscores Sapio’s commitment to operational excellence and elevating customer delivery across global markets
Leo James, Greg Jefferis and Marta Zlatic elected to Royal Society
Leo James, Greg Jefferis and Marta Zlatic, all Group Leaders at the LMB, have been elected Fellows of the Royal Society.
Enhanced breast cancer screening could detect an extra 3,500 cancers per year
Researchers in Cambridge are calling for additional scans to be added to breast screening for women with very dense breasts. This follows a large-scale trial, which shows that extra scans could treble cancer detection for these women potentially saving up to 700 lives a year in the UK.
Cleanroom Solutions embracing the future to elevate their large-scale facility construction provision
The Guardtech Group’s heritage turnkey brand are utilising state-of-the-art software to take their offering to another level
Enhancing public safety with reliable cellular coverage
Enhancing Public Safety with Reliable Cellular Coverage
£1 billion BioNTech investment sets way for jobs, growth, breakthroughs
Covid-19 vaccine pioneers BioNTech commit to up to £1 billion, 10-year investment in the UK.
Introducing Quoll Biosciences – Qkine’s new partner in Oceania
Cambridge, UK and Sydney, Australia - Qkine Ltd., a specialist recombinant protein manufacturer and Quoll Biosciences a specialist scientific distributor are pleased to announced their partnership to distribute Qkine high-quality proteins to Australia, New Zealand and Oceania.
Cambridge VC investment surges to $2.3 billion as science-led innovation abounds
Cambridge startups and scaleups raised an impressive $2.3 billion in 2024, the second-best year on record and almost double 2023’s $1.2 billion.
Xampla’s plant protein microcapsules spotlighted in Royal Society of Chemistry journal
New peer-reviewed research in the Royal Society of Chemistry journal Sustainable Food Technology, shows Xampla’s novel plant protein microcapsules retain oil-based activities through simulated digestion, all the way to the intestinal phase.
Maxion Therapeutics doubles R&D space at Unity Campus after £58 million Series A fundraise
Cambridge - Leading regional property investor and developer Howard Group, is delighted to announce that pioneering biotechnology company Maxion Therapeutics has more than doubled its footprint at Unity Campus.